1/39
Comprehensive vocabulary flashcards reviewing nervous system anatomy, physiology, neurological disorders, and neuropharmacology.
Neuron
The smallest functional unit of the nervous system that runs throughout the body carrying messages back and forth.
Dendrites
Neuronal projections that receive incoming electrical impulses.
Cell Body
The central part of a neuron that processes electrical messages before they enter the axon.
Myelin Sheath
A specialized insulating layer wrapped around an axon that facilitates and speeds electrical impulse conduction.
Central Nervous System (CNS)
The main structural division of the nervous system consisting of the brain and spinal cord.
Peripheral Nervous System (PNS)
The structural division of the nervous system located outside the CNS, composed of cranial nerves and spinal nerves.
Afferent Neurons
Sensory neurons that carry incoming signals from peripheral tissues to ARRIVE at the CNS.
Efferent Neurons
Motor neurons that EXIT the CNS to carry outgoing motor impulses to muscles and organs to trigger an effect.
Cranial Nerves
Twelve pairs of nerves originating directly in brain tissue, designated by Roman numerals and descriptive names, carrying sensory and/or motor fibers.
Spinal Nerves
A total of 31 pairs of nerves protected by the vertebral column, categorized into 8 cervical, 12 thoracic, 5 lumbar, 5 sacral, and 1 coccygeal pair.
Blood-Brain Barrier (BBB)
A protective barrier that shields the brain by selectively permitting only specific types of small, lipid-soluble molecules to enter.
Somatic Nervous System
A voluntary branch of the PNS that relays motor signals to skeletal muscles and receives sensory impulses (smell, taste, touch, hearing).
Autonomic Nervous System
An involuntary division of the PNS that regulates smooth muscles, cardiac muscle, and secretory glands.
Sympathetic Nervous System (SNS)
The 'Fight or Flight' branch of the autonomic nervous system originating from thoracic and lumbar regions that shuts down nonessential systems and redirects energy to muscles under stress.
Parasympathetic Nervous System (PNS)
The 'Rest and Digest' branch of the autonomic nervous system that slows heart rate, activates the digestive system, and operates during restful periods.
Neurotransmitters
Chemical messengers produced and released by neurons that bind to specific receptors to excite or inhibit target nerve cells or tissues.
Agonist
A drug or substance ('imposter') that mimics the action of a natural neurotransmitter by binding to its receptor (e.g., morphine mimicking endorphins).
Antagonist
A drug or substance ('blocker') that inhibits or blocks neurotransmitter receptors to prevent activation (e.g., botox blocking acetylcholine).
Sympathomimetics (Adrenergics)
Pharmacological agents that stimulate the sympathetic nervous system by mimicking endogenous adrenergic neurotransmitters.
Sympatholytics
Pharmacological agents (adrenergic blocking agents) that block sympathetic nervous system receptors, named after the specific receptor blocked (e.g., beta blockers).
Alpha-1 (α1) Receptors
Adrenergic receptors located in peripheral blood vessels, eyes, and heart that mediate pupillary dilation, increased heart rate, and peripheral vasoconstriction upon activation.
Beta-1 (β1) Receptors
Adrenergic receptors primarily located in cardiac tissue that increase heart rate upon stimulation.
Beta-2 (β2) Receptors
Adrenergic receptors located in the respiratory tract and blood vessels that trigger bronchial dilation upon stimulation.
Anticholinergics
Drugs that block receptors for acetylcholine or inhibit its activity within the central and peripheral nervous systems.
Epilepsy
A seizure disorder driven by hyperexcitability of brain neurons, diagnosed using an EEG, and categorized into partial or generalized seizures.
Anticonvulsants
Medications that prevent abnormal CNS impulses by inhibiting ion channels involved in nerve conduction (e.g., Dilantin, Keppra, Tegretol).
Alzheimer’s Disease
A degenerative, progressive brain condition marked by memory loss, disorientation, and decreased production of acetylcholine.
Parkinson’s Disease
A slow, progressive movement disorder caused by a deficiency or loss of the neurotransmitter dopamine.
Sinemet (Levodopa/Carbidopa)
The 'Gold Standard' antiparkinsonian medication combination formulated to elevate dopamine levels in the brain.
Multiple Sclerosis (MS)
An autoimmune disorder in which the immune system attacks and destroys the myelin sheath of CNS axons, replacing it with sclerotic tissue.
Myasthenia Gravis
A rare autoimmune neuromuscular disorder disrupting impulse transmission from the CNS to skeletal muscles, frequently presenting with eyelid drooping.
Polyneuropathy
A neurological condition characterized by distal sensory loss, burning, numbness, tingling, or weakness, commonly secondary to diabetes, alcoholism, or HIV.
Monoamine Oxidase Inhibitors (MAOIs)
An antidepressant class (e.g., Nardil/phenelzine) that inhibits the breakdown of monoamines throughout the body and requires strict adherence to drug and food restrictions.
Tricyclic Antidepressants (TCAs)
Antidepressant agents (e.g., amitriptyline, nortriptyline) that elevate mood by inhibiting the reuptake of both serotonin and norepinephrine.
Selective Serotonin Reuptake Inhibitors (SSRIs)
First-line antidepressant agents (e.g., fluoxetine, sertraline, citalopram) that specifically prevent the reuptake of serotonin.
Tardive Dyskinesia
A potentially irreversible adverse effect of antipsychotics characterized by involuntary repetitive movements of facial muscles, tongue, jaw, and head.
Narrow Therapeutic Index (NTI)
A narrow margin where minute differences in drug dose or blood concentration can precipitate serious therapeutic failure or life-threatening adverse reactions.
Clozapine REMS
A mandatory shared risk mitigation program enforcing blood absolute neutrophil count monitoring ('No Blood, No Drug') to prevent severe neutropenia and agranulocytosis.
Tall Man Lettering
A safety lettering strategy capitalizing unique letter combinations in look-alike, sound-alike (LASA) drug names (e.g., buPROPion vs. busPIRone) to prevent dispensing errors.
Schedule II (CII) Substances
Controlled substances with high abuse potential that cannot be refilled or transferred, but may have up to three sequential prescriptions issued for a maximum 90-day supply.